HAVAS LYNX LAUNCHES NEW WHITE PAPER "CLIMATE OF HEALTH"

Havas Lynx, a global healthcare communications agency, has released a white paper titled "Climate of Health" that examines the significant effects of climate change on human health. The World Health Organization has identified the climate crisis as a major global health threat, attributing one in four deaths to preventable environmental causes. Projections indicate that by 2050, climate change could lead to an additional 14.5 million deaths and $12.5 trillion in economic losses worldwide. The white paper discusses the implications of climate change across various medical fields, including respiratory diseases, oncology, mental health, and diabetes. It highlights the growing awareness among healthcare professionals (HCPs) regarding the climate crisis, with 77% recognizing it as a risk to patient health. Furthermore, 62% of HCPs believe that the climate crisis is changing the patient demographics they encounter. The findings reveal that HCPs are increasingly considering environmental factors in their clinical decisions, with 41% aiming to prescribe products from responsible pharmaceutical brands. Additionally, over half of HCPs are more inclined to prescribe environmentally friendly products. The expectations for pharmaceutical companies to take action against climate change are rising, with 72% of HCPs advocating for corporate responsibility in this area. Havas Lynx aims to leverage this data to guide clients in making impactful decisions that benefit both their brands and public health. The agency emphasizes the importance of addressing the climate-health crisis, not only as a moral obligation but also as a critical business strategy for the pharmaceutical industry.